 |
methyldopa |
|---|---|
| Trade Name | |
| Orphan Indication | Type 1 diabetes in DQ8 positive patients with residual beta cell function |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-12 00:00:00 |
| Sponsor | IM Therapeutics LLC;11001 West 120th Avenue, Suite 400;Broomfield, Colorado, 80021 |
